Active-specific immunotherapy for non-small cell lung cancer

Non-small cell lung cancer constitutes about 85% of all newly diagnosed cases of lung cancer and continues to be the leading cause of cancer-related deaths worldwide. Standard treatment for this devastating disease, such as systemic chemotherapy, has reached a plateau in effectiveness and comes with...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Winter, Hauke, van den Engel, Natasja K., Rusan, Margareta, Schupp, Nina, Poehlein, Christian H., Hu, Hong-Ming, Hatz, Rudolf A., Urba, Walter J., Jauch, Karl-Walter, Fox, Bernard A., Rüttinger, Dominik
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Pioneer Bioscience Publishing Company 2011
Gaiak:
Review Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3256502/
https://ncbi.nlm.nih.gov/pubmed/22263073
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2010.12.06
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak